10.29.25 -- DCT Benefits Are Proven, Yet Progress Is Slow

Explore the future of cancer treatment driven by rising global incidence and investment. Learn about the novel modalities that are fueling a new era of precision medicine.

Plan your first overseas study or expand an established pipeline; with the help of strategic insights to navigate complexities, maximize investment, and position new therapies for international success.

As early phase clinical trials become more sophisticated, sponsors are now leveraging flexible IRT solutions to replace error-prone manual processes and gain greater control and efficiency.

A comprehensive review of optimal timing and methodologies for cognitive and pharmacodynamic testing during first-in-human trials on CNS-active compounds.

Our team in Japan provides comprehensive services including primary and secondary clinical packaging and labeling, comparator sourcing, cold chain storage, and local and global distribution.

To truly maximize enrollment in decentralized models, sponsors must invest in human connection to build the trust needed to move patients from awareness to active participation.